SJS Investment Consulting’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6K | Hold |
154
| – | – | ﹤0.01% | 337 |
|
2025
Q1 | $10.7K | Buy |
154
+4
| +3% | +$278 | ﹤0.01% | 357 |
|
2024
Q4 | $12.9K | Hold |
150
| – | – | ﹤0.01% | 324 |
|
2024
Q3 | $17.9K | Hold |
150
| – | – | ﹤0.01% | 294 |
|
2024
Q2 | $21.4K | Sell |
150
-410
| -73% | -$58.5K | ﹤0.01% | 259 |
|
2024
Q1 | $71.9K | Buy |
560
+410
| +273% | +$52.6K | 0.01% | 149 |
|
2023
Q4 | $15.5K | Hold |
150
| – | – | ﹤0.01% | 258 |
|
2023
Q3 | $13.6K | Sell |
150
-366
| -71% | -$33.3K | ﹤0.01% | 262 |
|
2023
Q2 | $41.8K | Buy |
516
+366
| +244% | +$29.6K | 0.01% | 164 |
|
2023
Q1 | $11.9K | Hold |
150
| – | – | ﹤0.01% | 270 |
|
2022
Q4 | $10.2K | Sell |
150
-974
| -87% | -$65.9K | ﹤0.01% | 284 |
|
2022
Q3 | $56K | Buy |
+1,124
| New | +$56K | 0.02% | 153 |
|
2022
Q1 | $25K | Hold |
458
| – | – | 0.01% | 269 |
|
2021
Q4 | $26K | Buy |
+458
| New | +$26K | 0.01% | 238 |
|